Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes.

Nasu, H; Hibi, N; Ohyashiki, J H; Hara, A; Kubono, K; Tsukada, Y; Ando, K; Iwama, H; Hayashi, S; Yahata, N; Toyama, K; Ohyashiki, K

Nasu, H; Hibi, N; Ohyashiki, J H; Hara, A; Kubono, K; Tsukada, Y; Ando, K; Iwama, H; Hayashi, S; Yahata, N; Toyama, K; Ohyashiki, K.

Affiliation

Nasu H; SRL, Inc., Hachioji, Tokyo 192, Japan.

Int J Oncol ; 13(3): 525-30, 1998 Sep.

Article in En | MEDLINE | ID: mdl-9683788

Subject(s)

Hyaluronan Receptors/blood; Leukemia/blood; Myelodysplastic Syndromes/blood; Acute Disease; Animals; Antibodies, Monoclonal; Enzyme-Linked Immunosorbent Assay; Humans; Isomerism; Leukemia/diagnosis; Mice; Myelodysplastic Syndromes/diagnosis; Myeloproliferative Disorders/blood; Myeloproliferative Disorders/diagnosis; Solubility

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia / Hyaluronan Receptors Type of study: Diagnostic_studies Limits: Animals / Humans Language: En Journal: Int J Oncol Journal subject: NEOPLASIAS Year: 1998 Document type: Article Affiliation country: Japan

Search on Google

Add to My VHL

XML

PubMed Links